Genmab — Maj 2016
-
Beløbet er med i Genmabs guidance, så det skal vel ikke betyde så meget på kursen
-
Milestone er med i guidance. Det skriver Genmab i børsmeddelelsen. Uptake nok hurtigere end ventet
-
@Legolas. Genmab skriver: This milestone was included in Genmab's previously issued financial guidance for 2016.
-
Jeg er enig med dig i at prisforhandlinger er gået hurtige end jeg havde forventet, og det kan have positiv effekt på salgstal for juni og fremover, specielt da vi har lært at patienter for hyppigere dosering i de første måneder
-
Ved det ikke. Får vi nok besked om den 22 juni, når de kommer næste gang
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind